{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:23:27Z","timestamp":1768980207374,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002462","name":"Chungnam National University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002462","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00705-018-3837-3","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T11:57:03Z","timestamp":1522843023000},"page":"2073-2083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Inactivated enterovirus 71 with poly-\u03b3-glutamic acid\/Chitosan nano particles (PC NPs) induces high cellular and humoral immune responses in BALB\/c mice"],"prefix":"10.1007","volume":"163","author":[{"given":"Prabuddha S.","family":"Pathinayake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. A.","family":"Gayan Chathuranga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Cheol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Y. E.","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon-Hee","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"key":"3837_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12250-011-3195-8","volume":"4","author":"KB Chua","year":"2011","unstructured":"Chua KB, Kasri AR (2011) Hand foot and mouth disease due to enterovirus 71 in Malaysia. Virol Sin 4:221\u2013228","journal-title":"Virol Sin"},{"key":"3837_CR2","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","volume":"10","author":"T Solomon","year":"2010","unstructured":"Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH (2010) Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10:778\u2013790","journal-title":"Lancet Infect Dis"},{"key":"3837_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3345\/kjp.2016.59.10.395","volume":"59","author":"KY Lee","year":"2016","unstructured":"Lee KY (2016) Enterovirus 71 infection and neurological complications. Korean J Pediatr 59:395\u2013401","journal-title":"Korean J Pediatr"},{"key":"3837_CR4","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/BF02253368","volume":"7","author":"CK Yu","year":"2000","unstructured":"Yu CK, Chen CC, Chen CL, Wang JR, Liu CC, Yan JJ, Su IJ (2000) Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci 7:523\u2013528","journal-title":"J Biomed Sci"},{"key":"3837_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0264-410X(01)00385-1","volume":"20","author":"CN Wu","year":"2001","unstructured":"Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS (2001) Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20:895\u2013904","journal-title":"Vaccine"},{"key":"3837_CR6","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.micinf.2007.06.002","volume":"9","author":"DG Foo","year":"2007","unstructured":"Foo DG, Alonso S, Chow VT, Poh CL (2007) Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect 9:1299\u20131306","journal-title":"Microbes Infect"},{"key":"3837_CR7","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1016\/j.vaccine.2011.04.070","volume":"29","author":"EJ Bek","year":"2011","unstructured":"Bek EJ, Hussain KM, Phuektes P, Kok CC, Gao Q, Cai F, Gao Z, McMinn PC (2011) Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection. Vaccine 29:4829\u20134838","journal-title":"Vaccine"},{"key":"3837_CR8","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1016\/j.vaccine.2011.01.094","volume":"29","author":"CW Chen","year":"2011","unstructured":"Chen CW, Lee YP, Wang YF, Yu CK (2011) Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine. Vaccine 29:2772\u20132776","journal-title":"Vaccine"},{"key":"3837_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/JVI.00999-09","volume":"84","author":"KC Ong","year":"2010","unstructured":"Ong KC, Devi S, Cardosa MJ, Wong KT (2010) Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol 84:661\u2013665","journal-title":"J Virol"},{"key":"3837_CR10","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1099\/vir.0.80784-0","volume":"86","author":"M Arita","year":"2005","unstructured":"Arita M, Shimizu H, Nagata N, Ami Y, Suzaki Y, Sata T, Iwasaki T, Miyamura T (2005) Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J Gen Virol 86:1391\u20131401","journal-title":"J Gen Virol"},{"key":"3837_CR11","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1128\/JVI.01798-07","volume":"82","author":"M Arita","year":"2008","unstructured":"Arita M, Ami Y, Wakita T, Shimizu H (2008) Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD\/SCID mouse infection model. J Virol 82:1787\u20131797","journal-title":"J Virol"},{"key":"3837_CR12","doi-asserted-by":"publisher","first-page":"9386","DOI":"10.1128\/JVI.02856-06","volume":"81","author":"M Arita","year":"2007","unstructured":"Arita M, Nagata N, Iwata N, Ami Y, Suzaki Y, Mizuta K, Iwasaki T, Sata T, Wakita T, Shimizu H (2007) An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol 81:9386\u20139395","journal-title":"J Virol"},{"key":"3837_CR13","first-page":"944","volume":"24","author":"HF Chen","year":"2006","unstructured":"Chen HF, Chang MH, Chiang BL, Jeng ST (2006) Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine 24:944\u20132951","journal-title":"Vaccine"},{"key":"3837_CR14","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1016\/j.vaccine.2008.03.041","volume":"26","author":"HL Chen","year":"2008","unstructured":"Chen HL, Huang JY, Chu TW, Tsai TC, Hung CM, Lin CC, Liu FC, Wang LC, Chen YJ, Lin MF, Chen CM (2008) Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine 26:2882\u20132889","journal-title":"Vaccine"},{"key":"3837_CR15","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1023\/A:1024071514438","volume":"25","author":"YC Hu","year":"2003","unstructured":"Hu YC, Hsu JT, Huang JH, Ho MS, Ho YC (2003) Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells. Biotechnol Lett 25:919\u2013925","journal-title":"Biotechnol Lett"},{"key":"3837_CR16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3748\/wjg.v12.i6.921","volume":"12","author":"YC Chung","year":"2006","unstructured":"Chung YC, Huang JH, Lai CW, Sheng HC, Shih SR, Ho MS, Hu YC (2006) Expression, purification and characterization of enterovirus-71 virus-like particles. World J Gastroenterol 12:921\u2013927","journal-title":"World J Gastroenterol"},{"key":"3837_CR17","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.vaccine.2008.01.058","volume":"26","author":"YC Chung","year":"2008","unstructured":"Chung YC, Ho MS, Wu JC, Chen WJ, Huang JH, Chou ST, Hu YC (2008) Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 26:1855\u20131862","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"3837_CR18","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/S0264-410X(02)00165-2","volume":"20","author":"LS Keith","year":"2002","unstructured":"Keith LS, Jones DE, Chou CH (2002) Aluminum toxicokinetics regarding infant diet and vaccinations. Vaccine 20(Suppl 3):S13\u2013S17","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"3837_CR19","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/S0264-410X(02)00168-8","volume":"20","author":"CJ Clements","year":"2002","unstructured":"Clements CJ, Griffiths E (2002) The global impact of vaccines containing aluminium adjuvants. Vaccine 20(Suppl 3):S24\u2013S33","journal-title":"Vaccine"},{"key":"3837_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1473-3099(04)00927-2","volume":"4","author":"T Jefferson","year":"2004","unstructured":"Jefferson T, Rudin M, Di Pietrantonj C (2004) Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence. Lancet Infect Dis 4:84\u201390","journal-title":"Lancet Infect Dis"},{"key":"3837_CR21","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.2174\/092986711795933740","volume":"18","author":"L Tomljenovic","year":"2011","unstructured":"Tomljenovic L, Shaw CA (2011) Aluminum vaccine adjuvants: are they safe? Curr Med Chem 18:2630\u20132637","journal-title":"Curr Med Chem"},{"key":"3837_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1515\/REVEH.1991.9.4.191","volume":"9","author":"H Meiri","year":"1991","unstructured":"Meiri H, Banin E, Roll M (1991) Aluminum ingestion\u2014is it related to dementia? Rev Environ Health 9:191\u2013205","journal-title":"Rev Environ Health"},{"key":"3837_CR23","doi-asserted-by":"publisher","first-page":"31578","DOI":"10.1038\/srep31578","volume":"6","author":"M Mold","year":"2016","unstructured":"Mold M, Shardlow E, Exley C (2016) Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations. Sci Rep 6:31578","journal-title":"Sci Rep"},{"key":"3837_CR24","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1021\/bm049312a","volume":"6","author":"YH Lin","year":"2005","unstructured":"Lin YH, Chung CK, Chen CT, Liang HF, Chen SC, Sung HW (2005) Preparation of nanoparticles composed of chitosan\/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells. Biomacromolecules 6:1104\u20131112","journal-title":"Biomacromolecules"},{"key":"3837_CR25","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1128\/CVI.00505-09","volume":"17","author":"T Hamasaki","year":"2010","unstructured":"Hamasaki T, Uto T, Akagi T, Akashi M, Baba M (2010) Modulation of gene expression related to Toll-like receptor signaling in dendritic cells by poly(gamma-glutamic acid) nanoparticles. Clin Vaccine Immunol 17:748\u2013756","journal-title":"Clin Vaccine Immunol"},{"key":"3837_CR26","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/intimm\/dxp065","volume":"21","author":"S Kim","year":"2009","unstructured":"Kim S, Yang JY, Lee K, Oh KH, Gi M, Kim JM, Paik DJ, Hong S, Youn J (2009) Bacillus subtilis-specific poly-gamma-glutamic acid regulates development pathways of naive CD4(+) T cells through antigen-presenting cell-dependent and -independent mechanisms. Int Immunol 21:977\u2013990","journal-title":"Int Immunol"},{"key":"3837_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.vetmic.2012.05.035","volume":"160","author":"HJ Moon","year":"2012","unstructured":"Moon HJ, Lee JS, Talactac MR, Chowdhury MY, Kim JH, Park ME, Choi YK, Sung MH, Kim CJ (2012) Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate\/chitosan nanoparticles induces protection against highly pathogenic influenza A virus. Vet Microbiol 160:277\u2013289","journal-title":"Vet Microbiol"},{"key":"3837_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.vetmic.2017.01.020","volume":"201","author":"MY Chowdhury","year":"2017","unstructured":"Chowdhury MY, Kim TH, Uddin MB, Kim JH, Hewawaduge CY, Ferdowshi Z, Sung MH, Kim CJ, Lee JS (2017) Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate\/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes. Vet Microbiol 201:240\u2013251","journal-title":"Vet Microbiol"},{"key":"3837_CR29","doi-asserted-by":"publisher","first-page":"44839","DOI":"10.1038\/srep44839","volume":"7","author":"J Yang","year":"2017","unstructured":"Yang J, Shim SM, Nguyen TQ, Kim EH, Kim K, Lim YT, Sung MH, Webby R, Poo H (2017) Poly-\u03b3-glutamic acid\/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine. Sci Rep 7:44839","journal-title":"Sci Rep"},{"key":"3837_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-1-62703-287-2_8","volume":"980","author":"MJ Baine","year":"2013","unstructured":"Baine MJ, Mallya K, Batra SK (2013) Quantitative real-time PCR expression analysis of peripheral blood mononuclear cells in pancreatic cancer patients. Methods Mol Biol 980:157\u2013173","journal-title":"Methods Mol Biol"},{"issue":"4","key":"3837_CR31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402\u2013408","journal-title":"Methods"},{"key":"3837_CR32","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1084\/jem.162.2.663","volume":"162","author":"A Yamada","year":"1985","unstructured":"Yamada A, Ziese MR, Young JF, Yamada YK, Ennis FA (1985) Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli. J Exp Med 162:663\u2013674","journal-title":"J Exp Med"},{"key":"3837_CR33","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1016\/j.vaccine.2006.06.036","volume":"25","author":"A Khajuria","year":"2007","unstructured":"Khajuria A, Gupta A, Singh S, Malik F, Singh J, Suri KA, Satti NK, Qazi GN, Srinivas VK, Gopinathan Ella K (2007) RLJ-NE-299A: a new plant based vaccine adjuvant. Vaccine 25:2706\u20132715","journal-title":"Vaccine"},{"key":"3837_CR34","first-page":"37","volume":"79","author":"WF Brown","year":"1964","unstructured":"Brown WF (1964) Variance estimation in the Reed-Muench fifty per cent end-point determination. Am J Hyg 79:37\u201346","journal-title":"Am J Hyg"},{"key":"3837_CR35","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1016\/j.vaccine.2010.05.004","volume":"28","author":"S Broos","year":"2010","unstructured":"Broos S, Lundberg K, Akagi T, Kadowaki K, Akashi M, Greiff L, Borrebaeck CA, Lindstedt M (2010) Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy. Vaccine 28:5075\u20135085","journal-title":"Vaccine"},{"key":"3837_CR36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/vaccines3020320","volume":"3","author":"AD Pasquale","year":"2015","unstructured":"Pasquale AD, Preiss S, Silva FTD, Gar\u00e7on N (2015) Vaccine Adjuvants: from 1920 to 2015 and Beyond. Vaccines 3:320\u2013343","journal-title":"Vaccines"},{"key":"3837_CR37","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s12026-013-8403-1","volume":"56","author":"CA Shaw","year":"2013","unstructured":"Shaw CA, Tomljenovic L (2013) Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity. Immunol Res 56:304\u2013316","journal-title":"Immunol Res"},{"key":"3837_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jinorgbio.2013.07.022","volume":"128","author":"CA Shaw","year":"2013","unstructured":"Shaw CA, Li Y, Tomljenovic L (2013) Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes. J Inorg Biochem 128:237\u2013244","journal-title":"J Inorg Biochem"},{"key":"3837_CR39","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3233\/JAD-2010-101494","volume":"23","author":"L Tomljenovic","year":"2011","unstructured":"Tomljenovic L (2011) Aluminum and Alzheimer\u2019s disease: after a century of controversy, is there a plausible link? J Alzheimers Dis 23:567\u2013598","journal-title":"J Alzheimers Dis"},{"key":"3837_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tox.2016.11.018","volume":"375","author":"G Crepeaux","year":"2017","unstructured":"Crepeaux G, Eidi H, David MO, Baba-Amer Y, Tzavara E, Giros B, Authier FJ, Exley C, Shaw CA, Cadusseau J, Gherardi RK (2017) Non-linear dose-response of aluminium hydroxide adjuvant particles: Selective low dose neurotoxicity. Toxicology 375:48\u201357","journal-title":"Toxicology"},{"key":"3837_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.morpho.2015.12.003","volume":"100","author":"C Exley","year":"2016","unstructured":"Exley C (2016) The toxicity of aluminium in humans. Morphologie 100:51\u201355","journal-title":"Morphologie"},{"key":"3837_CR42","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nri2510","volume":"9","author":"P Marrack","year":"2009","unstructured":"Marrack P, McKee AS, Munks MW (2009) Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol 9:287\u2013293","journal-title":"Nat Rev Immunol"},{"key":"3837_CR43","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1002\/cbdv.200900283","volume":"7","author":"H Poo","year":"2010","unstructured":"Poo H, Park C, Kwak MS, Choi DY, Hong SP, Lee IH, Lim YT, Choi YK, Bae SR, Uyama H, Kim CJ, Sung MH (2010) New biological functions and applications of high-molecular-mass poly-gamma-glutamic acid. Chem Biodivers 7:1555\u20131562","journal-title":"Chem Biodivers"},{"key":"3837_CR44","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1128\/IAI.68.10.5764-5770.2000","volume":"68","author":"A Bacon","year":"2000","unstructured":"Bacon A, Makin J, Sizer PJ, Jabbal-Gill I, Hinchcliffe M, Illum L, Chatfield S, Roberts M (2000) Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens. Infect. Immun. 68:5764\u20135770","journal-title":"Infect. Immun."},{"key":"3837_CR45","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.vaccine.2003.11.011","volume":"22","author":"S Gogev","year":"2004","unstructured":"Gogev S, de Fays K, Versali MF, Gautier S, Thiry E (2004) Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1. Vaccine 22:1946\u20131953","journal-title":"Vaccine"},{"key":"3837_CR46","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0264-410X(98)00077-2","volume":"16","author":"I Jabbal-Gill","year":"1998","unstructured":"Jabbal-Gill I, Fisher AN, Rappuoli R, Davis SS, Illum L (1998) Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice. Vaccine 16:2039\u20132046","journal-title":"Vaccine"},{"key":"3837_CR47","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0264-410X(01)00423-6","volume":"20","author":"MA Westerink","year":"2001","unstructured":"Westerink MA, Smithson SL, Srivastava N, Blonder J, Coeshott C, Rosenthal GJ (2001) ProJuvant (Pluronic F127\/chitosan) enhances the immune response to intranasally administered tetanus toxoid. Vaccine 20:711\u2013723","journal-title":"Vaccine"},{"key":"3837_CR48","first-page":"491","volume":"5","author":"GA Duque","year":"2014","unstructured":"Duque GA, Descoteaux A (2014) Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol 5:491","journal-title":"Front Immunol"},{"key":"3837_CR49","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.11.4.569","volume":"11","author":"EY Denkers","year":"1998","unstructured":"Denkers EY, Ricardo T, Gazzinelli RT (1998) Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11:569\u2013588","journal-title":"Clin Microbiol Rev"},{"key":"3837_CR50","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1099\/vir.0.81195-0","volume":"86","author":"ML Liu","year":"2005","unstructured":"Liu ML, Lee YP, Wang YF, Lei HY, Liu CC, Wang SM, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK (2005) Type I interferons protect mice against enterovirus 71 infection. J Gen Virol 86:3263\u20133269","journal-title":"J Gen Virol"},{"key":"3837_CR51","doi-asserted-by":"publisher","first-page":"e1002352","DOI":"10.1371\/journal.ppat.1002352","volume":"8","author":"RM Welsh","year":"2012","unstructured":"Welsh RM, Bahl K, Marshall HD, Stina L (2012) Type 1 interferons and antiviral CD8 T-cell responses. PLoS Pathog 8:e1002352","journal-title":"PLoS Pathog"},{"issue":"49","key":"3837_CR52","doi-asserted-by":"publisher","first-page":"8270","DOI":"10.1016\/j.vaccine.2007.09.051","volume":"25","author":"S Okamoto","year":"2007","unstructured":"Okamoto S, Yoshii H, Akagi T, Akashi M, Ishikawa T, Okuno Y et al (2007) Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity. Vaccine 25(49):8270\u20138278","journal-title":"Vaccine"},{"key":"3837_CR53","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1203\/01.pdr.0000238247.86041.19","volume":"60","author":"LY Chang","year":"2006","unstructured":"Chang LY, Hsiung CA, Lu CY, Lin TY, Huang FY, Lai YH, Chiang YP, Chiang BL, Lee CY, Huang LM (2006) Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res 60:466\u2013471","journal-title":"Pediatr Res"},{"key":"3837_CR54","doi-asserted-by":"publisher","first-page":"e64024","DOI":"10.1371\/journal.pone.0064024","volume":"8","author":"RY Cao","year":"2013","unstructured":"Cao RY, Dong DY, Liu RJ, Han JF, Wang GC, Zhao H, Li XF, Deng YQ, Zhu SY, Wang XY, Lin F, Zhang FJ, Chen W, Qin ED, Qin CF (2013) Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection. PLoS One 8:e64024","journal-title":"PLoS One"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-018-3837-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-018-3837-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-018-3837-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:18:26Z","timestamp":1744175906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-018-3837-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["3837"],"URL":"https:\/\/doi.org\/10.1007\/s00705-018-3837-3","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,4]]},"assertion":[{"value":"20 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants by any of the authors. All animal experiments were conducted strictly in accordance with Guide for the Care and Use of Laboratory Animals (National Research Council, 2011) with the approval of Institutional Animal Care and Use committee of Bioleaders Corporation, Daejeon, South Korea. (reference number: BSL-ABSL-14-000).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}